Brand Reference: Compounded Subcutaneous NAD+
| Metric | Verified Benchmark | Source |
|---|---|---|
| Nicotinamide Adenine Dinucleotide (NAD+ Sterile) RxNorm Concept ID | 7315 | U.S. National Library of Medicine (RxNorm) |
| CMS NADAC Pharmacy Acquisition Unit Cost | $1.8500 / unit | CMS Medicaid NADAC Weekly Feed |
| Walk-In Chain Pharmacy Cash Average | $240.00 / mo | CMS NADAC + U.S. Retail Markup Index |
| Mark Cuban Cost Plus Wholesale Price | $135.00 / mo (Direct TeleMed) | Direct Telehealth Formulary |
| Community Mean Out-of-Pocket Paid | $145.00 / mo | 19 Zero-PHI Verified Patient Logs |
Replenishes intracellular oxidized nicotinamide adenine dinucleotide pools depleted by age-related CD38 ectoenzyme activity, serving as an obligate substrate for nuclear PARP1 DNA strand repair, mitochondrial SIRT3 deacetylation, and electron-transport chain NADH/NAD+ redox coupling.
Out-of-pocket price dispersion on Nicotinamide Adenine Dinucleotide (NAD+ Sterile) spans $145.00 to $240.00 per 30-day fill: pharmacy acquisition benchmarks sit near $1.8500/unit, allowing cash buyers bypassing PBM spread pricing to retain $95.00 each month (40% reduction).
With Rapid plasma cellular uptake (< 45 min); tissue NAD+ elevation 24–72h residence kinetics and 100% parenteral / subcutaneous bioavailability, Nicotinamide Adenine Dinucleotide (NAD+ Sterile) undergoes cleaved by cd38/sirtuins to nicotinamide and recycled via nampt salvage pathway and establishes therapeutic activity over 30–90 minutes post-subcutaneous microdose.
Standard adult regimens span 25 mg SC 3x weekly, 50 mg SC 2–3x weekly, 100 mg SC twice weekly. Prescribers screen specifically against active malignancy under parp-targeted oncology care without oncologist clearance; known benzyl alcohol preservative allergy, while community micro-logs most frequently note transient chest warmth if injected fast (24% of reports), subcutaneous sting (18% of reports), nausea (9% of reports).
Across 19 verified cash-pay logs, Nicotinamide Adenine Dinucleotide (NAD+ Sterile) achieves a 82.10% Worth-It rating with out-of-pocket spend averaging $145.00/mo versus $240.00/mo walk-in retail.
Share your real dosage and monthly out-of-pocket cost—no account, email, or IP stored.
Switched to Local Pharmacy at 25 mg SC 3x weekly for Nicotinamide Adenine Dinucleotide (NAD+ Sterile); monthly out-of-pocket dropped to $127.60 compared with $240.00 retail.
Completed 10 weeks on Nicotinamide Adenine Dinucleotide (NAD+ Sterile) (50 mg SC 2–3x weekly). Zero notable side effects on steady dosing.
Consistent biomarker response on 100 mg SC twice weekly Nicotinamide Adenine Dinucleotide (NAD+ Sterile) sourced via Compounding ($168.20/mo cash pay without insurance prior authorization).